Related Experiment Videos
Withdrawing cardiovascular medications at a syncope clinic
1Department of Medicine for the Elderly, Bristol Royal Infirmary, Bristol BS2 8HW, UK.
Postgraduate Medical Journal
|May 26, 2001
Summary
Many patients experiencing falls and syncope may improve by stopping cardiovascular medications. This approach can reduce side effects and costs, with medication renewal often unnecessary after careful monitoring.
Area of Science:
- Cardiology
- Geriatrics
- Clinical Pharmacology
Background:
- Clinical practice often assumes cardiovascular medications cause hypotension, leading to falls and syncope.
- Limited empirical evidence supports this common assumption regarding drug-induced falls and syncope.
Purpose of the Study:
- To investigate the impact of discontinuing cardiovascular medications in patients presenting with falls or syncope.
- To determine the necessity of renewing these medications at follow-up visits.
Main Methods:
- Analysis of data from patients attending a falls/syncope clinic where cardiovascular medications were stopped.
- Review of symptom changes and medication renewal requirements at subsequent appointments.
- Included 338 consecutive referrals, with 65 (19%) having cardiovascular medications discontinued.
Main Results:
- A significant majority (78%) of patients reported improvement in their presenting symptoms after medication cessation.
- Medication renewal was not required for 77% of patients on antianginals, 69% on antihypertensives, and 36% on antiarrhythmics.
- Discontinuation was feasible in a substantial proportion of patients under regular monitoring.
Conclusions:
- Adjusting cardiovascular medications is a viable strategy for managing falls and syncope.
- This approach may reduce the need for further interventions, side effects, and healthcare costs.
- Selective discontinuation of these drugs, with monitoring, can be beneficial for select patients.